obesity drug news today glp-1 october 23 2025 ADA '26: Lilly's dominance, Pfizer's 'foundational' and Roche's 'me-too' option Pharma Giants Bet on Next-Generation

Orlistat blocks your body from absorbing about a third of the fat you eat

Combining these advancements with other treatment modalities may further optimize their potential, creating a more comprehensive framework for managing T2DM and related metabolic disorders

Additionally, significant changes were noted in the composition of the bone matrix of these animals, with decreased enzymatic cross-linking of the collagenous matrix, which clearly worsened the compromised biomechanical strength and contributed to the observed bone fragility [44]

What the FDA prescribing labels actually say Let us start with what the regulatory authorities have on record

Endocrinology 136: 35853596

This makes Wegovy the first weight management medicine to gain a cardivascular risk reduction indication, showing significantly better results versus placebo